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ABSTRACT:
The exocrine pancreas’ function is to synthesize and secrete a battery of enzymes in response 
to secretagogues. Nitric oxide (NO) is a biological messenger in a variety of tissue types, 
eliciting an impressive variety of biological responses. Biosynthesis of NO in the pancreas is 
catalyzed by two known nitric oxide synthase isoforms, NOS(I) and NOS(II). However, the role 
of NO in secretion from pancreatic acinar cells has been unclear. The aim of this study was to 
determine the effects of nitric oxide on pancreatic secretion as well as its effects on enzymes 
specific to the ERK signaling cascade, which leads to synthesis of additional secretory vesicles. 
NO was shown to significantly promote pancreatic secretion most likely through a cGMP 
mechanism. In addition, NO was shown to promote phosphorylation of PI3K and ERK, hence 
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Introduction
W
The organs of the human body function in concert to achieve a desired 
physiological effect. The pancreas is unique in that it functions as both an 
endocrine and exocrine organ. Most of the pancreas is retroperitoneal and lies 
deep to the greater curvature of the stomach, extending across the abdomen. 
Histologically, the pancreas is divided into lobules by connective tissue septae. 
Lobules are composed largely (97%) of grape-like clusters of exocrine cells 
known as acini, which secrete digestive enzymes. Exocrine secretions from acini 
flow successively through intercalcated ducts, intralobular ducts, interlobular 
ducts and finally into the duodenum (Figure 1). Embedded within the pancreatic 
exocrine tissue are Islet of Langerhans, the endocrine component that comprises 
the remaining 3% of the pancreas. Five islet cell types, a-cells, p-cells, 8-cells, 
pancreatic polypeptide, and C-cells are known to exist, a-cells and p-cells serve 
to regulate blood glucose and insulin levels.
Chemical breakdown of food particles is initiated in the stomach where 
food is converted to chyme. As chyme is slowly released into the small intestine 
from the stomach, two things must happen: 1) acidic chyme must be quickly and 
efficiently neutralized to prevent damage to the duodenal mucosa and, 2) 
macromolecular nutrients (i.e. proteins, fats, and starch) must be further broken 
down before their components can be absorbed and delivered into the circulatory 
system. The function of the exocrine pancreas is to secrete acid-neutralizing 
bicarbonate plus a battery of enzymes that collectively have the capacity to
Figure 1. A Diagrammatic Representation of the Pancreas. Exocrine cells 
produce and secrete digestive enzymes into the small intestine where they 
aid in the digestion of proteins, carbohydrates, lipids, DNA, and RNA.
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reduce virtually all digestible macromolecules into forms that are capable of 
being absorbed. Four major groups of enzymes are critical to efficient digestion: 
pancreatic lipase, amylase, nucleases, and proteases. Proteases are 
synthesized as inactive proenzymes and packaged into secretory vesicles known 
as zymogens. The predominant pancreatic proteases are trypsin, chymotrypsin 
and carboxypeptidase. Once trypsinogen is released into the lumen of the small 
intestine, it is cleaved by the intestinal mucosa-embedded enzyme enterokinase, 
and thus rendered active. Once trypsin is formed, it activates chymotrypsinogen 
and pro-carboxypeptidase. Trypsin and chymotrypsin digest proteins into peptide 
fragments, which are ultimately digested into amino acid subunits by pancreatic 
carboxypeptidase and intestinal aminopeptidase. The other macromolecules are 
similarly digested with lipases cleaving fats into fatty acids, nucleases 
hydrolyzing DNA and RNA into nucleotides, and amylases cleaving complex 
carbohydrates into disaccharides such as maltose.
The principle stimulus to initiate pancreatic delivery of digestive enzymes 
into the small intestine is cholecystokinin (CCK). CCK is a linear peptide 
hormone synthesized in mucosal epithelial cells. It is released into the circulation 
in response to partially digested fats and proteins in the lumen of the duodenum. 
The elevation in blood concentration of CCK prompts two simultaneous actions in 
pancreatic acinar cells; the exocytotic release or secretion of digestive enzymes 
and the production of additional enzymes. These events lead to digestion and 
absorption of the very molecules that stimulate CCK secretion. Thus, when 
digestion and absorption are completed, CCK-induced secretion ceases.
CCK is the physiological signal that communicates the presence of 
macromolecules in the small intestine. The pancreas must therefore possess a 
sensor in the form of a plasma membrane CCK receptor that will initiate specific 
signal transduction pathways leading to product synthesis or enzyme release.
The CCK receptor is a 7-transmembrane domain protein and like all other similar 
proteins, links to a G-protein signal tranducer (Dabrowski et al., 1996). When the 
receptor is bound to CCK, it induces the associated G-protein to release GDP 
and bind GTP. Once bound to GTP, the alpha subunit of Gq dissociates from the 
Py subunits. The free GTP-bound a-subunit binds and allosterically activates 
PLCp. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5- 
triphosphate (IP3) and diacylglycerol (DAG). IP3 is water soluble and will bind to 
IP3 receptors on the endoplasmic reticulum promoting Ca2+ release from this 
intracellular store. Alternatively, DAG will activate specific PKC isoforms, which 
will in turn be required for other aspects of pancreatic functioning. PKC was 
originally identified as a serine/threonine kinase that was maximally active in the 
presence of DAG. Five PKC isoforms (a, 8, s, 0, and Q have been identified in 
pancreatic acinar cells that appear to exhibit specific patterns of lipid and calcium 
dependence for activity. Recent studies indicate that increased formation of NO 
is essential to activate PKCe in cardiac tissue (Ping et al., 1999). Additionally, 
Kein (2000) suggests that PKCs can activate the Raf protein in the ERK signaling 
pathway in pancreatic acinar cells. Therefore, it seems reasonable to suspect 
that NO may promote Raf activation via PKCs stimulation in pancreatic acinar
6The CCK receptor also initiates an additional signaling pathway that leads 
^  to phosphorylation of transcription factors and eventual replenishment of
secretory product. Initially, the CCK receptor activates a Src-type tyrosine 
kinase. Src in turn can phosphorylate tyrosine residues on the She scaffold 
protein, which appears to serve as a nucleation point in the assembly of the 
signaling complex (Park et al., 1999). She phosphorylation leads to the 
recruitment of adapter protein Grb2 via its SH2 domain. The SH2 domain is a 
region of approximately 100 amino acids that binds to phosphotyrosines on other 
proteins. The process of complexing Grb2 with She causes a conformational 
exposure of Grb2’s SH3 domain. The SH3 domain binds to proline-rich regions 
and provides an adapter function for subsequent protein interactions. Grb2 uses 
its SH3 domain to bind and activate SOS. SOS causes GDP to be replaced by 
V  GTP on Ras. Ras ia a monomeric G-protein family member activated upon
GDP/GTP exchange in response to diverse stimuli (Deora et al., 1998). Ras 
activation leads to an association and allosteric activation of Raf. Raf is a 
serine/threonine kinase which directly phosphorylates/activates MEK. MEK is a 
dual-specificity kinase that phosphorylates and activates extracellular signal- 
regulated kinase (ERK). Finally ERK, a ubiqitously expressed serine/threonine 
protein kinase, phosphorylates transcription factors that will bind to promoters 
and initiate transcription of genes important to continued secretion (Figure 2). 
Previous studies utilizing rat pancreatic acini have demonstrated that CCK 
strongly activates ERK as well as other upstream components of this signaling
Figure 2. A Model of the CCK Receptor Signal Transduction. Hormonal 
stimulation of plasma membrane receptors initiate a phosphorylation cascade 
beginning with the Src tyrosine kinase. Src phosphorylation of She initiates 
formation of a complex with Grb2 and SOS. Once this complex is formed, 
Ras is recruited and activated by binding to GTP. Subsequently, Ras 
allosterically activates Raf, and MEK and ERK are successively 
phosphorylated. ERK phosphorylates transcription factors which then 
translocate to the nucleus and promote the transcription of genes (mRNA) 




cascade, including the Shc-Grb2-S0S complex, MAPK kinase (MEK) and Ras 
(Dabrowski et al., 1996).
In direct competition with She phosphotyrosine receptor binding, 
phosphatidylinositol-3-kinase (PI3K) is also tyrosine-phosphorylated and 
subsequently activates an alternate or parallel cascade (Daulhac et al., 1999). 
PI3K is a cytoplasmic signaling molecule recruited to the membrane by 
phosphorylation. The 85 kDa non-catalytic regulatory subunit of PI3K links the 
catalytic 110 kDa subunit to activated protein receptors and is required for its 
activity. p110 phosphorylates various phosphotidylinositols at the 3 position of 
the inositol ring. This activity generates binding sites for proteins with pleckstrin 
homology domains and additional substrates for phospholipase C (PLC). 
Previous studies have revealed that some proteins involved in vesicle formation 
in other tissues are regulated by the phospholipids generated by PI3K (Fukui et 
al., 1998). Klippel et al. adds that PI3K activation is sufficient to activate multiple 
signal-transducing kinase pathways (1996). In other systems, SOS has been 
shown to possess pleckstin homology domains for activation. This observation 
provides an alternative PI3K-dependent activation route for Ras and downstream 
effectors. However, the distinct role of PI3K in vesicle formation and Ras 
activation in pancreatic acinar cells remains to be elucidated.
A novel signaling system that is proving important in many tissues, 
including the pancreas, is the nitric oxide (NO) generating system. Since its 
discovery as a biological signaling molecule in 1978 (Tannenbaum et al., 1978), 
nitric oxide research has become one of the most rapidly growing areas in
10
molecular biology with more than 20,000 publications to date. The importance of 
W  the discovery of NO is that it has revealed novel mechanisms in which signals
between cells can be generated. NO provides the first example of an 
intercellular messenger for which the cell membrane poses no significant barrier 
and which does not interact with a specific receptor to produce a response. NO 
can function as an intracellular messenger, an auto- or paracrine molecule, a 
neurotransmitter, or as a hormone that exerts its effects at multiple sites. Thus it 
is a unique simple molecule sanctioning an array of signal functions.
Consisting simply of one atom of nitrogen and one atom of oxygen, its 
biosynthesis is catalyzed by three known isoforms of nitric oxide synthase, 
neuronal NOS(I), inducible NOS(II), and endothelial NOS(III) (Lincoln et al., 
1997). These enzymes possess different biochemical properties and their 
expression is tissue dependent. Tissue specificity and different regulatory 
mechanisms suggest that NO concentrations must match specific functions in 
each tissue in which it is produced. Previous studies have indicated the 
presence of both NOS(I) and NOS(II) in the pancreas (Xu et al., 1997). NOS(I), 
also known as nNOS, is a constitutive isoform regulated at the post- 
transcriptional level by calmodulin (CaM) via a Ca2+-dependent mechanism 
(Michikawa et al., 1998). Intracellular Ca2+ concentrations greater than or equal 
to 400 nM are required for calmodulin to bind NOS and for the enzyme to 
become fully active. Therefore, at normal resting intracellular Ca2+ 
concentrations, NOS(I) is inactive. Additionally, activity of NOS(I) produces low 
levels (pmoles) of NO for a short period of time. In contrast, NOS(II), also known 
v
as iNOS, is activated independently of elevated intracellular Ca2+. Because 
NOS(II) inherently binds CaM, it becomes active shortly after its synthesis, 
regardless of intracellular Ca2+ concentration. Consequently, NOS(II) induces 
relatively higher amounts of NO (nmoles) for an extended period of time. This 
difference is thought to be important in terms of the Ca2+-influenced regulation of 
NO synthesis and its potential function.
In many instances NO mediates its effects by activating guanylyl cyclase, 
a heterodimeric hemoprotein. NO appears to bind to the heme moiety in the 
guanylyl cyclase prosthetic group and induces a conformational change in the 
enzyme (Schmidt et al., 1993). This results in the activation of the catalytic site 
and the synthesis of cyclic GMP (cGMP) from GTP (Zhao et al., 1999). Several 
studies have established cGMP as a mediator of intracellular Ca2+concentration. 
Murthy and Makhlouf suggest that cGMP stimulates Ca2+ release from an IP3- 
insensitive store (1998). Yoshida et al. reports that exogenous NO is capable of 
increasing endogenous cGMP, which results in an increase in the [Ca2+]i 
transient (1997). Furthermore, Xu et al. (1997) indicates that the production of 
even low levels of NO, generated specifically by NOS(I) prompts the activation of 
soluble guanylyl cyclase and production of cGMP. Thus, specific NOS isoforms 
seem to govern distinct effects on multiple pathways within the same cell.
NO appears to be widely distributed and exerts it effects on multiple 
systems throughout the body as well as within the cell. Its synthesis is catalyzed 
by two distinct isoforms in pancreatic acinar cells, NOS(I), which is dependent on 
Ca2+ concentration and NOS(II), which is not. Also, NO appears to both regulate
12
and be regulated by intracellular Ca2+ concentration through activation of cGMP
W  via soluble guanylyl cyclase. Although we have begun to understand the
intracellular signaling pathways activated by nitric oxide in other tissues, such 
information is not yet available in pancreatic acinar cells. It seems reasonable to 
ask if NO functions as an upstream signaling molecule in the ERK pathway in 
pancreatic acinar cells. Furthermore, acinar cell secretion is intimately coupled 
to Ca2+ and therefore begs the question: Is nitric oxide involved in the signaling 
cascades leading to acinar cell secretion? The purpose of this investigation was 
to further elucidate the role NO plays in both pancreatic acinar cell secretion and 





Isolation of Pancreatic Acini
Male Sprague-Dawley rats (125-190g) served as the source of pancreatic 
tissue. The rats were euthanized by light ether anaesthesia and subsequent 
cervical dislocation, a procedure approved by the NIL) IACUC committee. The 
pancreas was immediately dissected from the rat, minced thoroughly, and 
transferred to a 50ml culture tube containing 20ml Hank’s growth media (Medium 
199) and trypsin protease inhibitor (0.1 mg/ml). The tissue was then incubated in 
a shaking water bath at 37°C for ten minutes. The cell suspension was allowed 
to settle and the supernatant was removed. The pancreatic cells were washed 
and resuspended in an additional 20ml of growth medium prior to experimental 
treatment.
Chemicals
Reagents, antibodies, agonists and inhibitors used during this project were 
purchased from various biochemical companies in the United States. Pancreatic 
acinar cells were incubated in Medium 199 (Gibco BRL, Inc., Grand Island, NY), 
which contained essential electrolytes and amino acids. The incubation solution 
was supplemented with a variety of protease inhibitors including phenyl methyl 
sulfonyl fluoride (PMSF), (Sigma Chemical Company, St. Louis, MO), trypsin 
inhibitor (Gibco BRL, Inc.) and leupeptin. Protein A agarose beads were 
purchased from Boehringer Mannheim and were used to immunoprecipitate 
proteins following experimental treatments.
14
Primary antibodies including polyclonal mouse anti-phosphotyrosine lgG2b, 
W  polyclonal rabbit anti-Shc IgG, polyclonal rabbit anti-ERK2 IgG, and polyclonal
rabbit anti-PI3K IgG were purchased from Santa Cruz Biotechnology, Inc. 
Horseradish peroxidase labeled anti-rabbit IgG secondary antibody was also 
purchased from Santa Cruz Biotechnology, Inc.
Cholecystokinin, an effective physiological agonist for pancreatic 
secretion, was purchased from Sigma Chemical Company. 6-(2-hydroxy-1- 
methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9), is a nitric oxide 
donor with a release half-life of 3 minutes and was purchased from Calbiochem- 
Novabiochem Corporation. Inhibitors of various nitric oxide signal transduction 
pathways were also purchased from Calbiochem-Novabiochem Corporation and 
included N©-Nitro-L-Arginine-Methyl Ester, a broad based inhibitor of all NOS 
w  isoforms and NG-Propyl-L-arginine, a highly selective inhibitor of the NOS(I)
isoform.
Treatment of Pancreatic Acini
Experimental treatment of pancreatic acinar cells was performed at 37°C 
in a shaking water bath. Agonists and/or inhibitors were solubilized in 
concentrated stock solutions and appropriate aliquots were diluted directly into 
the cell suspension. In general, the cells were either assayed over a 30-minute 
time course to determine the rate of exocytotic secretion by the pancreatic acini, 
or alternatively, the cells were pelleted by centrifugation at 50g for three minutes
15
at room temperature. This resulting pellet was lysed and subsequently subjected 
W  to immunoprecipitation of tyrosine-phosphorylated proteins.
Immunoprecipitation.
Tyrosine phosphorylated proteins were extracted from the pancreatic 
acinar lysates by standard immunopreciptiation protocols. Acinar cell fractions 
were suspended and solubilized by homogenization (glass-Teflon potter) in an 
immunoprecipitation buffer containing 150mM NaCI, 50mM Tris-HCI [pH 7.5], 1% 
Nonidet P40, 0.5% deoxycholic acid, 2mM sodium orthovanidate, 1.4mM TPCK, 
0.1 mM leupeptin, 1mg/ml SDS, and 1mg/ml 100mM PMSF. The suspension was 
clarified by centrifugation at 12,000g for 10 minutes at 4°C. The recovered 
W  supernatant was incubated with 10pl phosphotyrosine antibody for 1 hour prior to
the addition of 30uL of protein-A agarose. The samples were then incubated 
overnight at 4°C on a rotator to maintain the agarose beads in suspension. 
Proteins bound to the agarose-conjugated phosphotyrosine antibody were 
collected by centrifugation at 12,000g for 30 seconds. The agarose beads 
containing the bound antibody and tyrosyl phosphorylated proteins were washed 
3 times in immunoprecipitation buffer for 20 minutes at 4°C. To remove 
additional nonspecifically bound proteins, the beads were then washed 3 times in 
high salt wash buffer (500mM NaCI, 50mM Tris-HCI [pH 7.5], 0.1% Nonidet P40) 
and collected by centrifugation at 12,000g for 30 seconds. The beads were then 
washed 3 more times in a low salt buffer (50mM Tris-HCL [pH 7.5], 0.1% Nonidet 
w
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P40) and again collected by centrifugation at 12,000g for 30 seconds. Finally, 
the protein-antibody complexes were dissociated from each other as well as the 
agarose beads by heating (95°C) in Laemmli reducing buffer (65.2mM Tris-HCI 
[pH 6.8], 25% glycerol, 2% SDS, 0.01% bromophenol blue, and 710mM (3- 
mercaptoethanol) and heated for 5 minutes at 95°C. The suspension was then 
centrifuged at 12,000g for 30 seconds, and the supernatant (containing all 
tyrosine phosphorylated proteins) was removed and aliquoted into 20pl samples 
and immediately frozen at -80°C.
Electrophoresis and Electroblotting
V
Frozen samples previously solubilized in laemmli reducing buffer were 
heated for 8 minutes at 95°C. After cooling, equal amounts of protein from each 
sample were loaded on a discontinuous SDS-polyacrylamide gel (gel 
composition of 4% acrylamide/bis-acrylamide in the stacking gel and 12% 
acrylamide/bis-acrylamide in the separating gel). The samples were 
electrophoresed at 100V for 60-75 minutes or until the bromophenol blue dye 
front reached approximately 1 to 2mm from the bottom of the gel. After 
electrophoresis, gels and nitrocellulose sheets were equilibrated for 15 minutes 
in transfer electrode buffer (192mM glycine, 20mM Tris, 20% methanol) to 
remove extraneous salts and detergents from the gel and to uniformly wet the 
nitrocellulose. Proteins were then electroblotted onto pure nitrocellulose
membrane for 1 hour at 100 volts at 4°C. The electroblot was performed with the 
Mini-Trans electroblotting apparatus (Bio-Rad Laboratories).
Western Blotting and Enhanced Chemiluminescence (ECL)
Following electroblotting, unoccupied reactive sites on the nitrocellulose 
sheet were blocked by rocking with 10% nonfat dry milk in TTBS (250mM NaCI, 
20mM Tris [pH 7.6], 0.05% Tween-20) for 1.5 hours at room temperature. 
Subsequent to blocking, nitrocellulose blots were washed 6 times with a TTBS 
solution on a rocker at room temperature for 5 minutes. After washing, 
nitrocellulose blots were incubated on a rocker overnight at 4°C in a solution 
containing 1% non-fat dry milk in TTBS and a 1:1000 dilution of either stock 
polyclonal rabbit anti- She, ERK2, or PI3K antibody. The blots were then washed 
6 times for 5 minutes each in TTBS on a rocker at room temperature.
Primary antibody binding to proteins was detected using a 1:2000 dilution 
of stock horseradish peroxidase labeled anti-rabbit IgG. The blot was incubated 
with the secondary antibody in 1 % non-fat dry milk in TTBS for 1 hour on a 
rocker at room temperature. Following the incubation with the secondary 
antibody, the blots were washed 6 times for 5 minutes each in TTBS on the 
rocker at room temperature. After the final wash, the blots were immediately 
incubated in luminol developer solution (equal volumes of cyclic diacylhydrazide 
luminol and alkaline enhancer). This method relied upon the ability of bound 
horseradish peroxidase to oxidize the luminol and thereby excite the cyclic
18
diacylhydrazide to a higher energy state. Once excited, the activated compound 
w /  decays to a lower energy state and in the process emits a photon of light
(wavelength max = 428nm). This chemiluminescence was detected using blue 
light-sensitive autoradiographic ECL Hyperfilm in a darkroom setting. This 
exposure was performed in a standard film-holding cassette for 15 seconds to 10 
minutes, depending on the antibody and the amount of starting sample. The 
exposed Hyperfilm was then developed and fixed in an automated film 
developer.
Protein Assay
Protein assays were performed using the Bio-Rad Bradford Protein Assay 
Kit with bovine serum albumin as a standard. Fractions were incubated in 4ml of 
a 1:4 dilution of protein dye stock solution for 15 minutes at room temperature. 
Individual absorbencies were read with a Beckman DU-60 spectrophotometer at 
a wavelength of 595nm.
Amylase Assay
Amylase assays were performed by a modified version of Bernfeld (1955), 
to determine the extent of secretion from the pancreatic acini during treatment. 
Maltose was used as a disaccharide standard. Samples (25jliI) were incubated 
with 75|nl amylase resuspension buffer (0.2% Triton X-100, 50mM Tris, 100mM
NaCI, 10mM CaCI2) and 100|xl substrate (1% amylopectin, 40mM MOPS, 60mM 
NaCI) for 30 minutes in a 37°C water bath. This reaction was stopped with the 
addition of 0.2ml stop-development reagent (1% 3,5-dinitrosalicyclic acid, 0.4N 
NaOH, 1.06M sodium potassium tartarate). The resulting fractions were heated 
for 7 minutes at 95°C. The fractions were cooled and diluted with 2.6ml water. 
Individual absorbencies were read with a Beckman DU-60 spectrophotometer at 
a wavelength of 530nm. Amylase release was then plotted as a function of time.
Image Scanning and Quantification
Following western blotting and enhanced chemiluminescense, protein 
bands on the ECL film were acquired using the computer program Adobe 
Photoshop 5.0. These scanned protein bands were then quantified using the 





CCK is the definitive stimulus for release of preformed secretory vesicles 
containing pancreatic enzymes (Yoshida et al., 1997). This assertion was 
verified experimentally when isolated cells were treated with 20nM CCK.
Figure 3 shows that CCK caused a pronounced and sustained increase in the 
rate of amylase release over the course of a 30-minute period when compared to 
a control from the same tissue preparation. On average, CCK caused 30% of 
total amylase to be released over 30 minutes, whereas unstimulated cells 
released only 8% over the same time course. Activation of pancreatic acinar 
cells is thought to promote NO synthesis and two isoforms have been shown to 
be expressed (Xu et al., 1997). To determine the effect of nitric oxide on 
amylase release, pancreatic acinar cells were treated with 1 mM NOC-9, a nitric 
oxide donor. Figure 4 shows that NOC-9 alone strongly stimulates amylase 
release, comparable in magnitude to that of CCK-induced stimulation. This result 
suggests that nitric oxide generation by NOC-9 is sufficient to promote a full 
secretory response, independent of plasma membrane receptor activation. To 
elucidate whether endogenous NO production contributes to the CCK response 
and whether the NOS isoforms exhibited differential effects on amylase 
secretion, isolated cells were treated with NOS inhibitors prior to incubation with 
20nM CCK. The responses were then compared to cells from the same 
preparation treated with CCK alone. Figure 5 illustrates that when NO synthesis 
is inhibited, the secretory response to CCK stimulated secretion is blunted.
Figure 3. The Effect of CCK Treatment on Pancreatic Secretion (Amylase 
Release). Control (♦) represents the percent of total amylase secretion over 
a 30-minute time period from untreated cells. CCK (0) represents the percent 
of total amylase secretion over a 30-minute time period from CCK (20nM) 
treated cells. Cells were suspended in Medium 199 at 37°C and samples 


































Figure 4. The Effect of NOC-9 on Pancreatic Amylase Secretion. Control (♦) 
represents the percent of total amylase secretion over a 30-minute time 
period from untreated cells. NOC-9 (□) represents the percent of total 
amylase secretion over a 30-minute time period from NOC-9 (1 mM) treated 
cells. Cells were suspended in Medium 199 at 37°C and samples were drawn 
from the suspension solution at the indicated time points.
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Figure 5. CCK (•) represents the percent of total amylase secretion over a 
30-minute time period from cells treated with CCK (20nM). L-NAME + CCK 
(□) represents the percent of total amylase secretion over a 30-minute time 
period from L-NAME (1mM) plus CCK (20nM) treated cells.
N-Propvl-aroinine (□) represents the percent of total amylase secretion over a 
30-minute time period from N-Propyl-arginine (1 mM) plus CCK (20nM) 
treated cells. Cells were suspended in Medium 199 at 37°C and samples 
were drawn from the suspension solution at the indicated time points.
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When isolated cells were incubated with the broad-based NOS inhibitor L-NAME 
W  (1 mM), subsequent stimulation with 20nM CCK was totally blocked. However,
when cells from the same preparation were treated with the specific NOS(I) 
inhibitor, the CCK response was inhibited by only 50%. This result either 
suggests a synergistic response between the two NOS isoforms or that NOS(II) 
is preferentially important for the exocytotic branch of secretion.
CCK stimulation of pancreatic acinar cells is known to lead to activation of 
intermediates in the ERK signaling pathway (Dabrowski et al., 1997). This 
assertion was confirmed when cells were incubated with 20nM CCK and 
immunoprecipitated for phospho-tyrosine. Figure 6 shows that cells incubated 
with CCK induced a 137% ± 72 rise in She phosphorylation, when compared to a 
control that received no treatment. Similarly, CCK induced a 131% ± 12 rise in 
w  ERK tyrosyl-phosphorylation (Figure 7) and a 71 % ± 11 rise in PI3K tyrosyl-
phosphorylation (Figure 8).
To determine if NO influences the ERK-associated transcription branch of 
secretion, isolated pancreatic acinar cells were once again treated with 1mM 
NOC-9. Following 5 minutes incubation, the cells were immunoprecipitated with 
anti-phosphotyrosine antibody and probed using antibodies specific for She, ERK 
or PI3K. Western blot analysis revealed that NOC-9 increases ERK2 
phosphorylation by 130% ± 15 when compared to a control that received no 
treatment. This level of phosphorylation was similar to that achieved using the 
physiological agonist CCK. Surprisingly, NOC-9 had no effect on She 
phosphorylation, which represents the proximal or initial component in the 
w
Figure 6. The Effect of NOC-9 and NO Inhibitors on She Phosphorylation, 
(a) CON represents the degree of phosphorylation in untreated pancreatic 
acinar cells (PACs). CCK represents the degree of phosphorylation in cells 
treated with CCK (20nM) for 5 minutes. LK represents the degree of 
phosphorylation in cells treated with L-NAME (1mM) plus CCK (20nM) for 5 
minutes, (b) CON represents the degree of phosphorylation in untreated 
pancreatic acinar cells (PACs). CCK represents the degree of 
phosphorylation in cells treated with CCK (20nM) for 5 minutes.
NPAK represents the degree of phosphorylation in cells treated with N- 









Figure 7. The Effect of NOC-9 and NO Inhibitors on ERK Phosphorylation.
(a) CON represents the degree of phosphorylation in untreated pancreatic 
acinar cells (PACs). CCK represents the degree of phosphorylation in cells 
treated with CCK (20nM) for 5 minutes. NOC-9 represents the degree of 
phosphorylation in cells treated with NOC-9 (1 mM) for 5 minutes. _LK 
represents the degree of phosphorylation in cells pretreated with L-NAME 
(1 mM) for 5 minutes prior to addition of CCK (20nM) for 5 minutes. NPAK 
represents the degree of phosphorylation in cells pretreated with N-Propyl- 
arginine (1mM) for 10 minutes prior to addition of CCK (20nM) for 5 minutes
(b) NIH imaging and quantification of Western blot results show that CCK 
and NOC-9 caused significant increases in the percent of tyrosyl 
phosphorylation for ERK. NOS inhibitors L-NAME and N-Propyl-arginine 
inhibited tyrosyl phosphorylation of ERK.































































Figure 8. The Effect of NOC-9 and NO Inhibitors on PI3K Phosphorylation.
(a) CON represents the degree of phosphorylation of in untreated pancreatic 
acinar cells (PACs). CCK represents the degree of phosphorylation in cells 
treated with CCK (20nM) for 5 minutes. NOC-9 represents the degree of 
phosphorylation in cells treated with NOC-9 (1 mM) for 5 minutes. _LK 
represents the degree of phosphorylation in cells pretreated with L-NAME
(1 mM) for 5 minutes prior to addition of CCK (20nM) for 5 minutes. NPAK 
represents the degree of phosphorylation in cells pretreated with N-Propyl- 
arginine (1 mM) for 10 minutes prior to addition of CCK (20nM) for 5 minutes.
(b) NIH imaging and quantification of Western blot results show that CCK and 
NOC-9 caused significant increases in the percent of tyrosyl phosphorylation 
for PI3K. NOS inhibitors L-NAME caused a significant reduction of 
N-Propyl-arginine inhibited tyrosyl phosphorylation of ERK.

hormone-induced cascade. This suggests that NO promotes ERK activation at a 
point downstream of She. Based upon reports that NO can mediate PI3K activity 
in other tissues (Pigazzi et al.t 1999) and that PI3K is an intermediate in the ERK 
pathway (Conway et al., 1999), the effect of NO on PI3K activation in isolated 
pancreatic acinar was also investigated. Therefore, NOC-9 treated cells were 
immunoprecipitated with anti-phosphotyrosine antibody and blotted with anti- 
PI3K. The results show that exogenous NO promoted a 71% ± 9 increase in 
PI3K phosphorylation when compared to cells that received no treatment.
In order to investigate whether the specific NOS isoforms present in 
pancreatic acinar cells exhibit differential effects on these same components in 
the ERK pathway, cells were incubated with either L-NAME or N-Propyl-arginine 
prior to stimulation with CCK. Figure 7 illustrates that when both isoforms are 
inhibited by L-NAME, ERK phosphorylation is reduced by 50%. However, when 
only NOS(I) is inhibited by N-Propyl-arginine, ERK phosphorylation is only 
slightly reduced by 3%. Likewise, L-NAME reduced PI3K phosphorylation by 
50% and N-Propyl-arginine failed to cause any significant reduction PI3K 
phosphorylation (Figure 8). Consistent with previously described results 
indicating that NOC-9 does not influence She phosphorylation, treatment with L- 
NAME or N-Propyl-arginine failed to alter CCK-induced phosphorylation of She 
(Figure 6). Together these results suggest that the NOS(I) isoform exerts no 
significant effect on any of the protein intermediates in the ERK signaling 
cascade. NOS(II), on the other hand, seems to have a pronounced effect on 
PI3K phosphorylation and a significant, although lesser, effect on ERK activation.
By implication, these results show that NO generated by NOS(II) preferentially 




Nitric oxide has now been associated with many physiological events. 
Palmer et al.f first identified NO as the endothelium-derived relaxing factor 
responsible for vasodilatation in cardiac tissue (1987). This discovery prompted 
subsequent NO research that gave rise to the identification of three NOS 
isoforms which generate NO, and characterized the differential effects generated 
by endogenous NO (Michel and Lamas, 1992). In 1993, Chen and Scholfield 
reported that NO modulates Ca2+ channels in neurons and Salter, Knowles and 
Moncada (1993) reported that an inducible form of NOS produced excess NO in 
response to lipopolysaccharide (LPS), which induces immune response. These 
disparate events are likely activated by similar NO-dependent mechanisms, as is 
the case for most second messengers.
Until recently, the only clearly defined NO-dependent mechanism was the 
activation of guanylyl cyclase. NO binds to the heme moiety of guanylyl cyclase 
to form a non-activated intermediate. Subsequent release of the heme ligand 
activates the enzyme (Zhao 1999). Activated guanylyl cyclase then triggers the 
formation of cGMP from GTP. The NO/cGMP system promotes Ca2+ influx by 
activating ionically-gated channels in the plasma membrane, and thus provides a 
mechanism for capacitative Ca2+ entry into the cell. The activation of Ca2+ influx 
is required for regulating cytosolic Ca2+ concentration, for refilling internal Ca2+ 
stores and for activating the exocytotic branch in pancreatic acinar cells (Muallem 
1989). Pandol et al., suggested that cGMP is sufficient to activate Ca2+ entry
and may mediate the effect of agonists on Ca2+ in acinar cells (1990). Because 
increased cytosolic Ca2+ concentration induces exocytosis of preformed vesicles 
and NO has been suggested to influence cGMP to regulate Ca2+ influx, the 
current experiments were performed to demonstrate a correlation between NO 
and amylase release from pancreatic acinar cells. The results showed that the 
NO donor NOC-9 alone promoted a sustained secretory response comparable in 
magnitude to that of the established exocytotic agonist, CCK. Furthermore, L- 
NAME inhibition of all NOS isoforms responsible for NO synthesis abolished 
CCK-induced secretory response, while selective inhibition of only NOS(I) with N- 
Propyl-arginine resulted in a reduced secretory response. These results suggest 
that both exogenous and endogenous NO are capable of stimulating the 
exocytotic branch in pancreatic acinar cells, as well as the appearance of a 
synergistic response between the two pancreatic NOS isoforms.
In summary, the results of this study provide evidence to support the 
assertions that NO mediates pancreatic exocytotic secretion. Since exocytosis is 
directly dependent on Ca2+ (Muallem 1989), NO likely acts in this situation 
through a cGMP-dependent mechanism. Either exogenous or endogenous NO 
can directly activate guanylyl cyclase, which in turn catalyzes the formation of 
cGMP from GTP. cGMP then promotes the appropriate Ca2+ influx which is 
required for exocytotic fusion between the secretory vesicle and apical plasma 
membrane.
The secretion of zymogen granules containing digestive enzymes 
necessitates the synthesis of additional granules via the ERK transcription
pathway in order to maintain the long-term responsiveness characteristic of the 
pancreas. As illustrated in Figure 9, hormonal stimulation of plasma membrane 
receptors initiate a phosphorylation cascade beginning with the Src tyrosine 
kinase. Src phosphorylation of She initiates formation of a complex with Grb2 
and SOS. Once this complex is formed, Ras is recruited and activated by 
binding to GTP. Subsequently, Ras allosterically Raf and MEK and ERK are 
successively phosphorylated. ERK phosphorylates transcription factors which 
then translocate to the nucleus and promote the transcription of genes (mRNA) 
necessary for the synthesis of proteins required for the formation of additional 
zymogen granules. Although an increase in cytosolic Ca2+ concentration has 
been shown to promote zymogen granule exocytosis, increased cytosolic Ca2+ 
concentration downregulates ERK phosphorylation (Kein 2000). Therefore, an 
alternate mechanism of activation of this pathway must exist. Recently, NO was 
demonstrated to activate ERK in postcapillary epithelium (Parenti et al., 1998). It 
seemed reasonable to postulate that NO may activate ERK in pancreatic acinar 
cells in a similar manner. Experiments in the preseqj study demonstrated a 
positive correlation between NO and ERK activation. Treatment of isolated 
acinar cells with NOC-9 caused in a 100% increase in ERK phosphorylation 
when compared to cells from the same preparation that received no treatment. 
This result suggests that exogenous NO alone is an effective activator of ERK. 
NOS inhibitor L-NAME inhibits endogenous NO production by all NOS enzymes. 
The degree of ERK phosphorylation in cells treated with L-NAME was markedly
)a2+
3
C a 2 +o Transcription Factors
Figure 9. A Model of the ERK Signaling Cascade. Hormonal stimulation of 
plasma membrane receptors initiate a phosphorylation cascade beginning 
with the Src tyrosine kinase. Src phosphorylation of She initiates formation of 
a complex with Grb2 and SOS. Once this complex is formed, Ras is recruited 
and activated by binding to GTP. Subsequently, Ras allosterically activates 
Raf, and MEK and ERK are successively phosphorylated. ERK 
phosphorylates transcription factors which then translocate to the nucleus and 
promote the transcription of genes (mRNA) necessary for the synthesis of 
proteins required for the formation of additional zymogen granules.
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reduced by 64%. Therefore, endogenous production of NO strongly mediates 
ERK phosphorylation as well.
Once NO was established to promote ERK phosphorylation, upstream 
components in the ERK cascade were investigated to determine possible sites of 
NO interaction. She is a scaffolding protein that serves as a recruitment site for 
other signaling proteins following tyrosyl-phosphorylation. She then serves as an 
initiation site for receptor-mediated phosphorylation and promotes activation of 
downstream proteins. NOC-9 did not significantly affect She phosphorylation. 
Treatment of acinar cells with NOS inhibitors similarly had no significant effect on 
She phosphorylation. These results suggest the NO promotes ERK activation via 
a Shc-independent mechanism and most likely interacts with components distal 
to She in the ERK signaling cascade. Components downstream of She and 
upstream of ERK include Ras, Raf and MEK. Recent studies have shown that 
NO is capable of directly interacting with Ras (Lander et al., 1995). NO catalyzes 
the formation of a nitrosothio group on Ras in a region that normally interacts 
with guanine nucleotide exchange factors (GEF). This interaction causes a 
conformational change in the protein structure of Ras. This event leads to the 
exchange of GDP for GTP, thereby energizing the Ras protein (Lander et al,
1995). Activation of Ras through this mechanism may be sufficient to promote all 
downstream events, including ERK phosphorylation.
Subsequent studies have also provided evidence to suggest that upon 
Ras activation by NO, the catalytic p110 subunit of PI3K is recruited to the 
activated portion of the Ras effector domain (Deora et al., 1998). It is thought
that by directly associating with Ras-GTP, PI3K becomes phosphorylated and 
activated. The phosphorylated lipid products of PI3K activity have various 
downstream targets including PKC and mitogen-activated protein kinase, ERK 
(Deora et al., 1998). Therefore, NO-activated Ras should promote both PI3K 
phosphorylation and ERK phosphorylation. The results of this investigation 
agree with this assertion, as the data showed that NOC-9 promoted PI3K 
phosphorylation and L-NAME decreased phosphorylation.
Previous work has also demonstrated that the PI3K-catalyzed production 
of phosphatidylinositol 3,4,5-trisphosphate (Ptd(3,4,5)P3), drives the allosteric 
activation of some PKC isoforms (Derman et al., 1997). In particular, recent 
studies suggest that the PKCs isoform in certain cell lines is activated through 
redundant and independent signaling pathways that require PI3K (Moriya et al., 
1996). In pancreatic acinar cells, PKCs has been suggested to activate Raf, a 
pivotal member of the ERK signaling cascade (Kein 2000). Other studies 
suggest that full Raf activity relies on both Ras and PKC. The cumulative data in 
these studies therefore suggest a parallel route in which PI3K contributes to 
ERK activation via PKCs. The data in the present study reveals that NO is potent 
stimulus of PI3K. Together these data provide evidence to suggest that NO 
activates ERK downstream of She and likely involves direct Ras activation which 
in turn promotes PI3K activation. These two signaling proteins act synergistically 
to activate Raf and all subsequent downstream events.
In conclusion, based upon the results of this study and in conjunction with 
previous findings, the following model is proposed (Figure 10).
Figure 10. A Model for the Interaction of NO with the ERK Signaling 
Cascade. Cholecystokinin binds to its receptor on the acinar cell plasma 
membrane and simultaneously initiates secretion as well as activation of the 
ERK cascade. NO catalyzes the formation of cGMP, which results in a 
sustained Ca2+ influx and initial enzyme secretion. NO also directly interacts 
with Ras, which in turn activates PI3K. The lipid products of PI3K activate 
PKCe. PKCs and Ras are required for activation of Raf and all downstream 
components of the ERK cascade.
Cholecystokinin binds to its receptor on the acinar cell plasma membrane and 
initiates two simultaneous actions: secretion of preformed zymogen granules 
containing digestive enzymes commences and the synthesis of additional 
product necessary for a sustained secretory. NOS(I) is activated by release of 
calcium from internal stores following receptor activation of PLC and IP3 
production. NO catalyzes the formation of cGMP, which results in a sustained 
Ca2+ influx and initial enzyme secretion. During this process, CCK-receptor 
activation also initiates the ERK cascade. Src binds the activated receptor, 
phosphorylates She, which in turn forms a complex with Grb2 and SOS. This 
complex induces Ras to release GDP and bind GTP. Successive components in 
the cascade, Raf, MEK and ERK are subsequently phosphorylated. ERK, the 
terminal enzyme in the cascade then initiates the synthesis of transcription 
factors necessary for the formation of NOS(II). Newly synthesized NOS(II) 
generates relatively large quantities of NO. NO will maintain Ras activity and in 
turn PI3K activity. Being a readily diffusable signal, NO can also amplify the 
overall tissue response by diffusing into adjacent cells and promoting Ras and 
PI3K activation in a paracrine manner as well. The products of the PI3K- 
catalyzed reaction, phosphatidylinositol 3,4,5-trisphosphate (Ptd(3,4,5)P3), will 
drive the allosteric activation of PKCe. PKCs and Ras are required for activation 
of Raf, which ultimately leads to the activation of ERK. Finally, ERK 
phosphorylates transcription factors necessary for mRNA production and the 
manufacture of additional secretory product and proteins involved in the
46
secretory response. Secretion is sustained in this manner until the initial stimulus 
W 1 has abated.
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